Arkolith/Insider Trading/KURA/Form 4

Wilson Troy Edward

President & CEO, DirectorKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Sep 9, 2025
Net Buying
Open-Market Buys
$410K
Open-Market Sells
$0
Net Open-Market Flow
$410K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 8, 2025Buy(P)50K$8.20$410K101K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-023974) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML